2026³â 04¿ù 12ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

HOLLYWOOD, FLA. -- The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in t

AI-enhanced intellectual property search solution simplifies complex research and expands curated content access.
´º½ºÀÏÀÚ: 2026-02-23

COLUMBUS, OHIO -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced complete functionality for CAS IP Finder™, powered by STN™. CAS STNext® customers can now access the full intellectual property search solution across all search methods, expanded content collections, and advanced analysis tools.

Patent volume continues to grow, and scientific disciplines are increasingly interconnected, making intellectual property research more complex and increasing the risk of missed prior art. Organizations traditionally chose between empowering specialized searchers with comprehensive tools or providing limited capabilities to broader teams. CAS IP Finder eliminates that compromise by providing flexible access points that connect users of all experience levels to curated content and precise search tools.

“As scientific and patent data grow in complexity, organizations need IP search solutions that enable access across entire teams,” said Manuel Guzman, President, CAS. “CAS IP Finder enables broader participation in IP research while maintaining the depth and accuracy that complex patent work demands, supporting faster, evidence-based decisions.”

Easier access to comprehensive databases without sacrificing precision

CAS IP Finder maintains access to more than 100 scientific, patent, and non-patent literature databases that have been the foundation of STN for decades. Now, users can search this wealth of data without command-line knowledge while preserving the precision IP professionals require. New capabilities include:

· An intuitive query builder enabling high-quality searches without traditional learning curves.
· Proprietary AI-enhanced exploratory search that analyzes text using machine learning and natural language processing.
· Expanded life sciences content embedded specifically to help IP professionals find critical information in complex datasets.
· Interactive visualization tools for exploring patterns in large datasets.
· Enhanced reporting features with customizable keyword highlighting and formatting options.

Among these capabilities, proprietary exploratory search stands out as a unique advancement in IP research, analyzing text input to identify relevant patents and non-patent documents, detecting key terms, and suggesting refinements that improve relevance without requiring specialized syntax knowledge. Patent examiners have adopted this approach because it delivers insights previously unavailable through conventional searches.

“The challenge was maintaining the precision and depth of CAS STNext while eliminating the traditional command-line barrier,” said Tim Wahlberg, Chief Product Officer, CAS. “Our proprietary exploratory search uses machine learning trained on the CAS Content Collection to deliver insights that patent examiners are now relying on. We have made complex IP research accessible without compromising accuracy.”

The solution also addresses specific needs in pharmaceutical and biotechnology research. The CAS Bioactivity file, curated by CAS scientists, provides normalized structure-activity relationships, ADME, and toxicity data structured specifically to support patent research workflows. This targeted approach helps researchers pinpoint critical information that would be difficult to locate through conventional methods, reducing risk in drug discovery and development.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Svante and Integrated Packaging Company Advance U.S. Biogenic CDR Project to Feasibility
Xsolla Releases New Industry Report Identifying the Biggest Opportunities for the Future of Video Games for Developers
Smartly Signs Letter of Intent to Acquire INCRMNTAL
STV Group and Post-Quantum Successfully Trial World¡¯s First Quantum-Resilient Drones
Axelspace Secures Japan Ministry of Defense Satellite Constellation Project
NTT DATA Launches NVIDIA-Powered AI Factories Driving Secure Adoption and ROI

 

Inside the 6G Coalition: LG Electronics and the Road To AI-Native Mobi...
Canva Introduces Magic Layers, Turning Static AI Outputs Into Editable...
C2N Diagnostics Partners BeauBrain to Launch Precivity Blood Tests for...
Xsolla Agency Launches to Empower Creators Across Entertainment-Based ...
Quectel Modules Demonstrate Compliance Readiness for EU Cyber Resilien...
NelsonHall Recognizes LTM as a Leader in GenAI & Process Automation fo...
Rochester Electronics Launches Refreshed South Korean Website

 


°øÁö»çÇ×
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ÃÁö'
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬银öõ(ÜÄÒ¬ÜØ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®À¯ºñ Alliuv ä¹备: ä¹êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..